HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosuvastatin Attenuates High-Salt and Cholesterol Diet Induced Neuroinflammation and Cognitive Impairment via Preventing Nuclear Factor KappaB Pathway.

Abstract
Recent attention is focused on the impact of diet on health and mental well-being. High-salt and cholesterol diet (HSCD) is known to be associated with neuroinflammation which is the predominant factor for neurodegenerative disease like Alzheimer disease (AD). In the present study, we examined the neuroprotective potential of rosuvastatin, an HMG-CoA reductase inhibitor against HSCD induced neuroinflammation and cognitive impairment. Our results demonstrated that HSCD-induced cognitive impairment as determined by Morris water maze (MWM) task. HSCD also activated nuclear factor kappaB (NF-kB) signaling pathway. The cytokine response was measured using a cytometric bead-based assay quantified by flow cytometry. Treatment with rosuvastatin decreased the production of nitric oxide (NO), tumor necrosis factor alpha (TNF-α) and increased interleukin-10 (IL-10) in a dose-dependent manner. Our results also demonstrated that the rosuvastatin modulates neuronal cell death by inhibiting the overexpression of NF-kB in the CA1 region of hippocampus. In addition, molecular docking study of rosuvastatin indicated high affinity and tighter binding capacity for the active site of the NF-kB. These results suggest that HSCD-triggered inflammatory response and cognitive impairment may be associated with NF-κB signaling pathway. Therefore, treatment with rosuvastatin could be a potential new therapeutic strategy for sporadic dementia of AD.
AuthorsIbraheem Husain, Mohd Akhtar, Divya Vohora, Malik Zainul Abdin, Mohammad Islamuddin, Mohd Jawaid Akhtar, Abul Kalam Najmi
JournalNeurochemical research (Neurochem Res) Vol. 42 Issue 8 Pg. 2404-2416 (Aug 2017) ISSN: 1573-6903 [Electronic] United States
PMID28417263 (Publication Type: Journal Article)
Chemical References
  • Cholesterol, Dietary
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Inflammation Mediators
  • NF-kappa B
  • Sodium Chloride, Dietary
  • Rosuvastatin Calcium
Topics
  • Animals
  • Brain (drug effects, metabolism)
  • Cholesterol, Dietary (adverse effects)
  • Cognitive Dysfunction (etiology, metabolism, prevention & control)
  • Female
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (pharmacology, therapeutic use)
  • Inflammation (etiology, metabolism, prevention & control)
  • Inflammation Mediators (antagonists & inhibitors, metabolism)
  • Maze Learning (drug effects, physiology)
  • Molecular Docking Simulation (methods)
  • NF-kappa B (antagonists & inhibitors, metabolism)
  • Rats
  • Rats, Wistar
  • Rosuvastatin Calcium (pharmacology, therapeutic use)
  • Signal Transduction (drug effects, physiology)
  • Sodium Chloride, Dietary (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: